Role of Stent Grafts in Aortic Aneurysm Management
The Aortic Aneurysm Market is heavily driven by the adoption of stent graft technology, which has revolutionized the treatment landscape for both abdominal and thoracic aortic aneurysms. Stent grafts, used in endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR), create a reinforced channel within the aorta, reducing pressure on the weakened vessel wall and preventing rupture.
Modern stent grafts are designed with flexibility and conformability to adapt to varied patient anatomies. Materials such as nitinol frames and durable graft fabrics ensure long-term stability, while low-profile delivery systems make implantation feasible for patients with smaller or more complex vascular pathways.
Recent innovations include fenestrated and branched stent grafts, which allow treatment of aneurysms involving critical arterial branches without compromising blood flow. Some research efforts are exploring drug-eluting grafts that may prevent post-procedure complications.
The market for stent grafts continues to expand as more patients opt for minimally invasive procedures over open surgery. With ongoing improvements in device durability and ease of deployment, stent grafts are expected to remain a cornerstone of aortic aneurysm management for the foreseeable future.